PT79871A - Process for preparing substituted hexahydro arylquinolizines - Google Patents
Process for preparing substituted hexahydro arylquinolizinesInfo
- Publication number
- PT79871A PT79871A PT79871A PT7987185A PT79871A PT 79871 A PT79871 A PT 79871A PT 79871 A PT79871 A PT 79871A PT 7987185 A PT7987185 A PT 7987185A PT 79871 A PT79871 A PT 79871A
- Authority
- PT
- Portugal
- Prior art keywords
- substituted hexahydro
- preparing substituted
- arylquinolizines
- hexahydro arylquinolizines
- antidiabetics
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 abstract 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- -1 antidiabetics Substances 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 229940127218 antiplatelet drug Drugs 0.000 abstract 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57623384A | 1984-02-02 | 1984-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT79871A true PT79871A (en) | 1985-02-01 |
| PT79871B PT79871B (en) | 1986-12-15 |
Family
ID=24303506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT79871A PT79871B (en) | 1984-02-02 | 1985-01-24 | Process for preparing substituted hexahydro arylquinolizines |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0154142B1 (pt) |
| JP (1) | JPS60188385A (pt) |
| KR (1) | KR900003651B1 (pt) |
| AT (1) | ATE44529T1 (pt) |
| AU (1) | AU576550B2 (pt) |
| CA (1) | CA1240677A (pt) |
| DE (1) | DE3571438D1 (pt) |
| DK (1) | DK45385A (pt) |
| ES (1) | ES8609323A1 (pt) |
| GR (1) | GR850211B (pt) |
| IE (1) | IE850253L (pt) |
| IL (1) | IL74147A (pt) |
| NZ (1) | NZ210982A (pt) |
| PT (1) | PT79871B (pt) |
| ZA (1) | ZA85789B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4690928A (en) * | 1984-02-02 | 1987-09-01 | Merck & Co., Inc. | Substituted hexahydro arylquinolizines as α2 blockers |
| GB8420602D0 (en) * | 1984-08-14 | 1984-09-19 | Wyeth John & Brother Ltd | Thienoquinolizines |
| DK127086A (da) * | 1985-03-25 | 1986-09-26 | Schering Corp | Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser |
| AU582663B2 (en) * | 1985-08-10 | 1989-04-06 | John Wyeth & Brother Limited | Sulphonamides |
| US4686226A (en) * | 1985-09-03 | 1987-08-11 | Merck & Co., Inc. | Substituted benzo[b]furo- and benzo[b]thieno quinolizines |
| US4835276A (en) * | 1986-07-03 | 1989-05-30 | Merck & Co., Inc. | Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 tetrahydrobenzo [b]furo [2,3-c]pyridine and derivatives |
| US4814452A (en) * | 1986-07-03 | 1989-03-21 | Merck & Co., Inc. | Enantioselective synthesis of 1,3,4,6,7,12b(S)-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin-2-one |
| US4831035A (en) * | 1986-08-28 | 1989-05-16 | Merck & Co., Inc. | Substituted hexahydroarylquinolizines |
| NZ221485A (en) * | 1986-08-28 | 1991-04-26 | Merck & Co Inc | Hexahydroarylquinolizine derivatives and pharmaceutical compositions |
| US4956365A (en) * | 1987-04-13 | 1990-09-11 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds |
| CA1321751C (en) * | 1989-02-21 | 1993-08-31 | Eugene C. Crichlow | Mechanism mediating ruminal stasis in ruminal lactic acidosis |
| JP5730896B2 (ja) | 2009-12-04 | 2015-06-10 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | トリシクロピラゾール誘導体 |
| GB201509006D0 (en) | 2015-05-26 | 2015-07-08 | Redx Pharma Plc | Antibacterial compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1470065C3 (de) * | 1961-06-19 | 1980-07-17 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren zur Herstellung von Chinolizinderivaten |
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
| US4181657A (en) * | 1978-07-14 | 1980-01-01 | Miles Laboratories, Inc. | 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders |
| GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
-
1985
- 1985-01-24 ES ES539799A patent/ES8609323A1/es not_active Expired
- 1985-01-24 GR GR850211A patent/GR850211B/el unknown
- 1985-01-24 IL IL74147A patent/IL74147A/xx unknown
- 1985-01-24 PT PT79871A patent/PT79871B/pt unknown
- 1985-01-25 DE DE8585100732T patent/DE3571438D1/de not_active Expired
- 1985-01-25 EP EP85100732A patent/EP0154142B1/en not_active Expired
- 1985-01-25 AT AT85100732T patent/ATE44529T1/de not_active IP Right Cessation
- 1985-01-29 NZ NZ210982A patent/NZ210982A/en unknown
- 1985-01-31 AU AU38220/85A patent/AU576550B2/en not_active Ceased
- 1985-01-31 CA CA000473300A patent/CA1240677A/en not_active Expired
- 1985-02-01 KR KR1019850000635A patent/KR900003651B1/ko not_active Expired
- 1985-02-01 DK DK45385A patent/DK45385A/da not_active Application Discontinuation
- 1985-02-01 JP JP60016693A patent/JPS60188385A/ja active Pending
- 1985-02-01 IE IE850253A patent/IE850253L/xx unknown
- 1985-02-01 ZA ZA85789A patent/ZA85789B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES8609323A1 (es) | 1986-07-16 |
| DE3571438D1 (en) | 1989-08-17 |
| GR850211B (pt) | 1985-05-24 |
| PT79871B (en) | 1986-12-15 |
| EP0154142A1 (en) | 1985-09-11 |
| ATE44529T1 (de) | 1989-07-15 |
| JPS60188385A (ja) | 1985-09-25 |
| IL74147A (en) | 1988-08-31 |
| ES539799A0 (es) | 1986-07-16 |
| KR850005843A (ko) | 1985-09-26 |
| AU576550B2 (en) | 1988-09-01 |
| ZA85789B (en) | 1986-09-24 |
| KR900003651B1 (ko) | 1990-05-28 |
| AU3822085A (en) | 1985-08-08 |
| IL74147A0 (en) | 1985-04-30 |
| EP0154142B1 (en) | 1989-07-12 |
| DK45385A (da) | 1985-09-18 |
| IE850253L (en) | 1985-08-02 |
| CA1240677A (en) | 1988-08-16 |
| NZ210982A (en) | 1988-04-29 |
| DK45385D0 (da) | 1985-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4127189A (en) | Benzimidazole derivatives, process for preparing the same and antiulcer agents containing the same | |
| FI891650L (fi) | Menetelmä oraalisen, hapossa pysymätöntä bentsimidatsolijohdannaista sisältävän valmisteen valmistamiseksi | |
| FI892823L (fi) | Menetelmä terapeuttisesti käyttökelpoisen (S)-1-(3-dimetyyliaminopropyyli)-1-(4'-fluorifenyyli)-1,3-dihydrobentsofuraani-5-karbonitriilin valmistamiseksi | |
| PT79871B (en) | Process for preparing substituted hexahydro arylquinolizines | |
| EP0556387A4 (en) | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,3-BUTANEDIOL. | |
| NO881537D0 (no) | Fremgangsmaate for fremstilling av 6-substituert-2',3'-dideoksynukleosider. | |
| DK299586D0 (da) | Saedeunderstoetning til stole, navnlig til drejelige arbejdsstole | |
| FI872255A7 (fi) | Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi | |
| AU547319B2 (en) | 1-(3-halo-2-pyridinyl) piperazine | |
| FI891129A7 (fi) | Menetelmä buteeni-I:n valmistamiseksi | |
| FI860602A0 (fi) | Anordning foer foersaettande i vertikal roerelse av en sits, isynnerhet en patientstol. | |
| NO881545L (no) | Nye pyrrolidin-2-(1,3-dikarbonyl)-derivater, samt fremgangsmaate for fremstilling derav. | |
| PT86059A (en) | Method for the memory:s improvement by means of the administration of agonist adrenergic selective of receiver for alpha-21 | |
| DE3877124D1 (de) | Imidazol-derivate, verfahren zu deren herstellung und deren anwendung als alpha-2-adrenoceptor-antagonisten. | |
| EP0204254A3 (en) | Substituted hexahydro arylquinolizines, processes for their preparation and pharmaceutical compositions containing them | |
| IT8520089A0 (it) | Procedimento per la preparazionedi w-lattami, in particolare caprolattame. | |
| FI855182A7 (fi) | Menetelmä 1,3-disubstituoitujen tetrahydropyridiinien valmistamiseksi. | |
| NO864695D0 (no) | Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler. | |
| SE8605202D0 (sv) | Bergborrkrona med riktade, svepande munstycken | |
| SE8704272D0 (sv) | Pharmaceutisk komposition | |
| IT1216951B (it) | Torretta verticale per tornio conpiu' utensili simultaneamente operanti. | |
| DE3262285D1 (en) | 4-oxo pgi2 derivatives, method for their preparation and their therapeutical compositions | |
| FI840254A7 (fi) | Menetelmä valmistaa +2-/(3,4- metyleenidioksi)-fenetyyli/-5-/(3-karboksamido-4-hydroksi)- - hydroksibentsyyli/pyrrolidiineja. | |
| IT8420686A1 (it) | "procedimenti per la preparazione di derivati del bis-idrossietilmercapto-1,10 - decano"/ | |
| IT8660326V0 (it) | Macchina per la produzione di spalliere per sedie. |